Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2684)
All Articles published online
|
Jun 14, 2009 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
van Geer MA, Bakker CT, Koizumi N, Mizuguchi H, Wesseling JG, Oude Elferink RP, Bosma PJ. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i22/2754.htm |
| Number | Citing Articles |
| 1 |
Michael Behr, Johanna K. Kaufmann, Patrick Ketzer, Sarah Engelhardt, Martin Mück-Häusl, Pamela M. Okun, Gabriele Petersen, Frank Neipel, Jessica C. Hassel, Anja Ehrhardt, Alexander H. Enk, Dirk M. Nettelbeck, Ilya Ulasov. Adenoviruses Using the Cancer Marker EphA2 as a Receptor In Vitro and In Vivo by Genetic Ligand Insertion into Different Capsid Scaffolds. PLoS ONE 2014; 9(4): e95723 doi: 10.1371/journal.pone.0095723
|
| 2 |
Karoly Toth, Debanjan Dhar, William SM Wold. Oncolytic (replication-competent) adenoviruses as anticancer agents. Expert Opinion on Biological Therapy 2010; 10(3): 353 doi: 10.1517/14712590903559822
|
| 3 |
Bethany Powell Gray, Kathlynn C. Brown. Combinatorial Peptide Libraries: Mining for Cell-Binding Peptides. Chemical Reviews 2014; 114(2): 1020 doi: 10.1021/cr400166n
|
| 4 |
Stavros P. Papadakos, Nikolaos Dedes, Nikolina Gkolemi, Nikolaos Machairas, Stamatios Theocharis. The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. International Journal of Molecular Sciences 2023; 24(3): 3015 doi: 10.3390/ijms24033015
|
| 5 |
Yue Pan, Xuewen Du, Fan Zhao, Bing Xu. Magnetic nanoparticles for the manipulation of proteins and cells. Chemical Society Reviews 2012; 41(7): 2912 doi: 10.1039/c2cs15315g
|
| 6 |
Ruiwu Liu, Xiaocen Li, Wenwu Xiao, Kit S. Lam. Tumor-targeting peptides from combinatorial libraries. Advanced Drug Delivery Reviews 2017; : 13 doi: 10.1016/j.addr.2016.05.009
|
| 7 |
Sayantan Mitra, Srinivas Duggineni, Mitchell Koolpe, Xuejun Zhu, Ziwei Huang, Elena B. Pasquale. Structure−Activity Relationship Analysis of Peptides Targeting the EphA2 Receptor. Biochemistry 2010; 49(31): 6687 doi: 10.1021/bi1006223
|
| 8 |
C Puig-Saus, L A Rojas, E Laborda, A Figueras, R Alba, C Fillat, R Alemany. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy. Gene Therapy 2014; 21(8): 767 doi: 10.1038/gt.2014.52
|
| 9 |
Otto Hemminki, Akseli Hemminki. Gene Therapy of Cancer. 2014; : 153 doi: 10.1016/B978-0-12-394295-1.00011-1
|
| 10 |
J PosthumaDeBoer, S R Piersma, T V Pham, P W van Egmond, J C Knol, A M Cleton-Jansen, M A van Geer, V W van Beusechem, G J L Kaspers, B J van Royen, C R Jiménez, M N Helder. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery. British Journal of Cancer 2013; 109(8): 2142 doi: 10.1038/bjc.2013.578
|
| 11 |
Elena B. Pasquale. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nature Reviews Cancer 2010; 10(3): 165 doi: 10.1038/nrc2806
|
| 12 |
S. A. Zozulya, I. P. Udovichenko. Eph family receptors as therapeutic targets. Russian Journal of Bioorganic Chemistry 2012; 38(3): 231 doi: 10.1134/S106816201203017X
|